
What smart money is saying about Pro-Dex Inc.
3 funds in our archive have pitched Pro-Dex Inc. — most recently SRK Capital in June 2026.
Pro-Dex, Inc. focuses on the development and manufacturing of advanced motorized surgical instruments. These sophisticated tools are supplied globally to original equipment manufacturers (OEMs) in the medical device sector. Their product portfolio features versatile, autoclavable (sterilization-friendly) surgical drivers and shavers, available in both battery-powered and electric models, often equipped with multi-functional capabilities. These instruments are primarily employed in orthopedic, thoracic, and craniomaxillofacial surgical procedures. Beyond its core manufacturing, Pro-Dex also offers expert consulting services, covering engineering, quality assurance, and regulatory compliance. Furthermore, the company manufactures and distributes rotary air motors to various industrial clients. Founded in 1978, Pro-Dex, Inc. maintains its corporate headquarters in Irvine, California.
Get an email when a fund buys, sells or pitches it
Position history
Between Q1 2026 and Q2 2026, 1 fund letter reported a position in Pro-Dex Inc., with 1 buy (opened or added).
| Quarter | Letters | Bought | Sold | Theses |
|---|---|---|---|---|
| Q2 2026 | 1 | 1 | 0 | 2 |
| Q1 2026 | 0 | 0 | 0 | 1 |
Bought and Sold count moves: the same sentence published by several funds of one house in a quarter counts once.
Fund activity · 1 position · 1 move
- AddedSRK CapitalJune 2026
“Pro-Dex Inc. (PDEX) Pro-Dex is a new holding added during the fourth quarter of last year.”
Pro-Dex Inc.
Fund coverage · 3 theses
- SRK CapitalJune 2026
Pro-Dex Inc. offers a durable medical device supply base, exclusive robotic surgery exposure, and asymmetric upside from CVRs and commercialization.
Read the full thesis PDEX could benefit from Zimmer’s mBos robot commercialization, with potential for a major operating cash flow transformation and much higher corporate value.
Read the full thesis- Long Cast AdvisersMarch 2026
PDEX is a critical contracted supplier with near-term earnings support and long-term upside tied to Monogram’s commercialization and valuation rights.
Read the full thesis
Read every full thesis on Pro-Dex Inc.
Unlock all 3 theses — the full reasoning behind what funds are buying, plus unlimited access to the entire archive.
View plans→